Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorUniversity of Edinburgh

About this trial

Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation.

Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes.

This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function.

The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.

Eligibility criteria

Qualifiers

Has kidney failure and is on the waitlist for a kidney transplant

Age 16 years and over

Able to give informed consent

Disqualifiers

Contraindication to CT scanning, including contrast allergy

Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation

Inability to give informed consent

Trial design

Treatments tested in this trial

  • Computed tomography coronary angiography (CTCA)

Treatment groups

332 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Edinburgh

Lead sponsor

Chief Scientist Office of the Scottish Government

Collaborator

University of Glasgow

Collaborator

NHS Lothian

Collaborator

NHS Greater Glasgow and Clyde

Collaborator